Health

How US-UK drug deal will benefit patients | Letters

Many new medicines have reached NHS patients as a result of the government’s reformed pricing arrangements, writes Richard Torbett .

Source Guardian AI Summary Updated 2h 29m ago

Story intelligence Beta

Freshness Fresh Updated 2h 29m ago

Confidence Checking

Coverage Checking

Views New Be the first to read

Read time 1 min ~58 words

AI Summary

Many new medicines have reached NHS patients as a result of the government’s reformed pricing arrangements, writes Richard Torbett . Plus a letter from Nick Hoile The suggestion that the US-UK pharmaceutical agreement will result in excess deaths is alarmist and relies on a heavily critiqued approach to modelling how much the NHS can spend to generate healt…

Read full article on The Guardian

AI summaries can be wrong sometimes—always verify important details using the source article.